Synchronyx Named Rising Star Winner at the 2026 Digital Health & AI Awards

Recognized at HLTH USA for connecting medication adherence, treatment persistence and patient engagement with timely care team support.

BOCA RATON, Fla., November 17, 2026 — Synchronyx, a digital health company focused on medication adherence and patient engagement, today announced that it has been named a Rising Star winner in the Therapeutics, Pharmacy & Medication Innovation category at the 2026 Digital Health & AI Awards. Presented by the Digital Health Hub Foundation, the awards were announced November 16 at HLTH USA in Las Vegas.

Synchronyx addresses a persistent gap in healthcare: what happens after a medication is prescribed and between patient visits. A prescription or refill record alone cannot explain whether a patient has started treatment, is struggling with side effects, has encountered an access barrier or needs help continuing therapy. These challenges can contribute to treatment interruptions, early discontinuation and patients becoming disconnected from care.

The company’s Tappt® platform turns the medication package into a connected care experience. With a tap of their smartphone on a battery-free smart label, patients can record a dose, access guidance, share a concern and connect with their care team. This simple interaction creates an opportunity to understand what patients are experiencing and provide support when it matters.

For care teams, that connection offers visibility into medication use, symptoms and barriers that might otherwise go unnoticed until the next appointment. It helps teams identify patients who may need assistance, understand why treatment has been interrupted and coordinate appropriate follow-up. The goal is to support adherence, persistence with prescribed therapy and continued engagement in care, while recognizing when a treatment change is clinically appropriate.

“Starting a medication is only the beginning. Patients need support to stay engaged in their care and continue treatment as intended,” said Tamar Sapir, PhD, founder and CEO of Synchronyx. “When someone misses a dose or stops responding, there is often a reason that deserves attention. We built Tappt to make those moments visible and help teams respond before a patient becomes disconnected from treatment or care.”

Synchronyx works with more than 40 health system and pharmacy partners and collaborates with life sciences organizations on patient support, clinical research and quality improvement programs. Tappt has been evaluated in peer-reviewed studies examining medication adherence, patient engagement and patient-reported outcomes. Programs can be tailored to different conditions and treatment regimens, including oral, injectable and infusion therapies.

For healthcare organizations and pharmacies, the platform supports continuity of care and patient retention by helping teams maintain contact beyond scheduled encounters. For life sciences partners, it provides a way to extend support throughout the treatment journey and better understand the factors influencing initiation, adherence and persistence. Data on patient experiences and barriers can inform improvements in patient services, care delivery and research.

“This recognition reflects years of collaboration with clinicians, pharmacists, researchers and life sciences partners, and the patients who have participated in these programs,” Sapir added. “Together, we are making the time between visits an opportunity to provide support and keep patients connected to care.”

The 2026 awards recognized 38 competitive winners from more than 1,300 participating companies worldwide, following multiple rounds of evaluation by experts across healthcare, technology, clinical medicine and investment.

About Synchronyx

Synchronyx is a digital health company connecting patient experiences to timely action across medication use and care transitions. Its Tappt® and Linkt™ solutions share a common platform that helps patients access support and enables teams to understand what happens between points of care. Synchronyx works with healthcare organizations, pharmacies and life sciences partners to support medication adherence, treatment persistence, patient retention and continuity of care. Learn more at www.synchronyx.com.

About Digital Health Hub Foundation

The Digital Health Hub Foundation supports healthcare technology companies in scaling and growing. Its annual Digital Health & AI Awards recognize companies advancing healthcare through technology across clinical care, patient access and care delivery. Learn more at www.digitalhealthhub.org.

Media contact
info@synchronyx.com

Next
Next

Synchronyx Named Finalist in Therapeutics, Pharmacy & Medication Innovation at the 2026 Digital Health & AI Awards